Mebendazole: A candidate FDA approved drug for repurposing in leukaemia

Kyle B. Matchett; Ivan V. Grishagin; Laura M. Kettyle; Gerald Gavory; Timothy Harrison; Ken Mills; Alexander Thompson

Mebendazole: A candidate FDA approved drug for repurposing in leukaemia

Kyle B. Matchett
, Ivan V. Grishagin
, Laura M. Kettyle
, Gerald Gavory
, Timothy Harrison
, Ken Mills
, Alexander Thompson

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Pages	121-122
Number of pages	1
Publication status	Published - 01 Apr 2016
Event	XXXVI World Congress International Society of Haematology - Glasgow, United Kingdom Duration: 18 Apr 2016 → 21 Apr 2016

Conference

Conference	XXXVI World Congress International Society of Haematology
Country/Territory	United Kingdom
City	Glasgow
Period	18/04/2016 → 21/04/2016

Cite this

@conference{f6e7daf9240442a8bcda33e3bd888ccf,

title = "Mebendazole: A candidate FDA approved drug for repurposing in leukaemia",

author = "Matchett, \{Kyle B.\} and Grishagin, \{Ivan V.\} and Kettyle, \{Laura M.\} and Gerald Gavory and Timothy Harrison and Ken Mills and Alexander Thompson",

year = "2016",

month = apr,

day = "1",

language = "English",

pages = "121--122",

note = "XXXVI World Congress International Society of Haematology ; Conference date: 18-04-2016 Through 21-04-2016",

}

TY - CONF

T1 - Mebendazole: A candidate FDA approved drug for repurposing in leukaemia

AU - Matchett, Kyle B.

AU - Grishagin, Ivan V.

AU - Kettyle, Laura M.

AU - Gavory, Gerald

AU - Harrison, Timothy

AU - Mills, Ken

AU - Thompson, Alexander

PY - 2016/4/1

Y1 - 2016/4/1

M3 - Abstract

SP - 121

EP - 122

T2 - XXXVI World Congress International Society of Haematology

Y2 - 18 April 2016 through 21 April 2016

ER -